How to Choose Second-Line Treatment for Hepatocellular Carcinoma

被引：0
|
作者：
Frenette, Catherine [1 ]
机构：
[1] MD Anderson Canc Ctr, Liver & Hepatocellular Canc Program Scripps, La Jolla, CA 77030 USA
来源：
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY | 2021年 / 19卷 / 11期
关键词：
DOUBLE-BLIND;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：726 / 729
页数：4
相关论文
共 50 条
  • [1] Metastatic Renal Cell Carcinoma: how to choose the appropriate second-line treatment?
    Borchiellini, Delphine
    [J]. BULLETIN DU CANCER, 2018, 105 : S242 - S254
  • [2] Regorafenib promising second-line treatment in hepatocellular carcinoma
    不详
    [J]. BRITISH JOURNAL OF HOSPITAL MEDICINE, 2016, 77 (08) : 446 - 446
  • [3] Cabozantinib as a second-line treatment option in hepatocellular carcinoma
    D'Angelo, Alberto
    Sobhani, Navid
    Bagby, Stefan
    Casadei-Gardini, Andrea
    Roviello, Giandomenico
    [J]. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2020, 13 (06) : 623 - 629
  • [4] Advancements in second-line treatment research for hepatocellular carcinoma
    Sun, Ruirui
    Wu, Chenrui
    Gou, Yang
    Zhao, Yaowu
    Huang, Ping
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2024,
  • [5] Preserving the Liver for Second-Line Treatment of Hepatocellular Carcinoma
    Lencioni, Riccardo
    [J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2016, 14 (12) : 6 - 8
  • [6] How Do You Choose a Second-Line Treatment Option for Depression?
    Weisler, Richard H.
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2010, 71 : 21 - 26
  • [7] Defining the Ideal Patient with Hepatocellular Carcinoma for Second-Line Treatment
    Roviello, Giandomenico
    Casadei-Gardini, Andrea
    Nobili, Stefania
    Mini, Enrico
    Fancelli, Sara
    [J]. JOURNAL OF ONCOLOGY, 2020, 2020
  • [8] Targeted agents for second-line treatment of advanced hepatocellular carcinoma
    Personeni, Nicola
    Pressiani, Tiziana
    Bozzarelli, Silvia
    Rimassa, Lorenza
    [J]. WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2019, 11 (10) : 788 - 803
  • [9] Targeted agents for second-line treatment of advanced hepatocellular carcinoma
    Nicola Personeni
    Tiziana Pressiani
    Silvia Bozzarelli
    Lorenza Rimassa
    [J]. World Journal of Gastrointestinal Oncology, 2019, (10) : 788 - 803
  • [10] Regorafenib as second-line therapy in hepatocellular carcinoma
    Duffy, Austin G.
    Greten, Tim F.
    [J]. NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2017, 14 (03) : 141 - 142
12345